Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Shanghai Baimaibo Pharmaceutical Co., Ltd., established on 2009-10-16, Business scope includes pharmaceutical and biotechnology products(human stem cells,Except genetic diagnosis and treatment)technology research and development,technical consulting,Technical Services,own technology transfer,Bioengineering products(Recombinant anti-tumor necrosis factor for injectionaHuman-Mouse Chimeric Monoclonal Antibody)production,Sell ​​self-produced products,Medical polymer materials and products,Wholesale of medical devices,import and export,commission agent(except auction),Li Bing Road, Pudong New Area301No. engaged in self-owned house rental,Engaged in the import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval)[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Zhangjiang Biotechnology Co., Ltd., established on 1998-12-07, Business scope includes biotechnology,biochemical,Genetic Engineering,Diagnostic reagents,Chemical Biological Reagent,Technology development for natural medicine expertise,technical consulting,Technical Services,technology transfer,Pilot test of self-developed products,Sales of laboratory reagents,Engaged in the import and export of goods and technology,Expo Services. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shanghai Maitai Junao Biotechnology Co., Ltd., established on 2012-05-30, Business scope includes general items:Biomedical Technology,Technology development in the field of detection technology,technical consulting,Technical Services,technology transfer,Specialty Chemicals(Free of Hazardous Chemicals),Manufacture and sale of bio-based materials,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals)promotion of,Engaged in the import and export of goods and technology.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Trustees of Dartmouth College, part of Dartmouth College, is a company headquartered in Hanover, NH. The firm operates higher education institutes. It was founded in 1769.

Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

INOFEA AG is a biotech company that offers a platform technology capable to fit enzymes in vivo and process conditions. The company was founded in 2014 and is headquartered in Basel, Switzerland.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Tekang Pharmaceutical Group Co., Ltd., established on 2018-04-24, Business scope includes licensed projects:Production of formula food for special medical purpose;food production;Health food production;Food additive production;Drug Wholesale;The second type of value-added telecommunications services;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Sales of formula food for special medical purposes;food sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Food Additive Sales;Chinese herbal medicine acquisition;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Technology Consulting Services;Health Consulting Services(Does not include medical services);Technology intermediary service.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA.

Tong Yan (Shanghai) Medical Equipment Co., Ltd., established on 2019-06-17, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Import and export;Technology Import and Export;Sales of Class I Medical Devices;Production of Class I Medical Devices;Sales of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.

Sanofi A/S engages in the production of prescription drugs as well as participates in clinical trials of present and future products. It specializes in diabetes, oncology, multiple sclerosis, rare disease and cardio vascular illnesses. The company is headquartered in Copenhagen, Denmark.

Manufactures pharmaceuticals

Taixing Dongsheng Biotechnology Co., Ltd., established on 2007-08-03, Business scope includes licensed projects:Food additive production;food production;food business;food business(Selling prepackaged food);food business(sell bulk food);Food Internet Sales(Selling prepackaged food);Import and export;Technology Import and Export;Food import and export;Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Research and development of bio-based material polymerization technology;Research and development of bio-based materials technology;R&D of industrial enzyme preparations;Food Additive Sales;trade broker;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;sales agent(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Yizhou (Shanghai) Biopharmaceutical Co., Ltd., established on 2020-07-29, Business scope includes general items:engaged in biotechnology(remove human stem cells,Development and application of genetic diagnosis and treatment technology),Technology development in the field of medical science and technology,technical consulting,Technical Services,technology transfer,Engineering and Technology Research and Experimental Development;Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Import and export,Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shenzhen Dimin Biotechnology Co., Ltd., established on 2013-06-21, Business scope includes general business items:A class of biomedical equipment,Development of reagents and software,Information Consulting;Class II biomedical equipment,Development of reagents and software,Information Consulting;Operating import and export business;Domestic Trade;Realtor.(Laws of the above items,Administrative regulations,Except for those prohibited by the decision of the State Council,Restricted projects must obtain a license before operating);electronics sales.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:A class of biomedical equipment,Production of reagents and software,Sales;Class II biomedical equipment,Production of reagents and software,Sales;Three types of biomedical equipment,Development of reagents and software,Production,Sales and information consultation.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.